Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: i. Patients suffering from cancer undergoing chemotherapy for the first time with neuro-toxic drugs. ii. Patients willing to participate iii. Above 18 years
Exclusion criteria
Exclusion criteria: i. Known case of Peripheral neuropathy(Diabeteic neuropathy, Raynaud’s syndrome, carpal tunnel syndrome) ii. Patients who are unable to report parasthesia and pain iii. Patients undergoing palliative chemotherapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| These are the intensity of the symptoms – paraesthesia, burning, and pain that will be assessed using the NCI- CTCAE guidelines and EORTC CIPN-20 questionnaires. Timepoint: Outcome variables of the participants will be assessed at before administrating each chemotherapy cycle, and at after 30 minutes of each chemotherapy cycle. | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of Life using EORTC-C30 toolTimepoint: At baseline, 3 months & at 6 months | — |
Countries
India
Contacts
National Institute of Nursing Education, PGIMER